857 related articles for article (PubMed ID: 17570263)
1. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
3. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.
Nácul AP; Andrade CD; Schwarz P; de Bittencourt PI; Spritzer PM
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):191-6. PubMed ID: 17049715
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?
Abdel Fattah NS; Darwish YW
Br J Dermatol; 2009 May; 160(5):1011-5. PubMed ID: 19298279
[TBL] [Abstract][Full Text] [Related]
7. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.
Aasen G; Fagertun H; Halse J
Scand J Clin Lab Invest; 2008; 68(3):204-11. PubMed ID: 18446527
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
10. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
Pekhlivanov B; Mitkov M; Orbtsova M; Terzieva D
Akush Ginekol (Sofiia); 2008; 47(3):15-9. PubMed ID: 18756827
[TBL] [Abstract][Full Text] [Related]
11. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.
Mario FM; do Amarante F; Toscani MK; Spritzer PM
Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259
[TBL] [Abstract][Full Text] [Related]
12. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
[TBL] [Abstract][Full Text] [Related]
13. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
Spritzer PM; Comim FV; Capp E; D'Avila A
Horm Metab Res; 2005 Feb; 37(2):94-8. PubMed ID: 15778926
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
15. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
Anaforoglu I; Algun E; Incecayir O; Ersoy K
Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
[TBL] [Abstract][Full Text] [Related]
16. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
17. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women.
Lee K; Lee S; Kim YJ; Kim YJ
Nutrition; 2008; 24(7-8):625-31. PubMed ID: 18485667
[TBL] [Abstract][Full Text] [Related]
18. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
19. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.
Wiltgen D; Benedetto IG; Mastella LS; Spritzer PM
Hum Reprod; 2009 Jul; 24(7):1726-31. PubMed ID: 19329517
[TBL] [Abstract][Full Text] [Related]
20. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
